Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.36) by 28.77 percent. This is a 31.58 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $5.289 million which beat the analyst consensus estimate of $4.995 million by 5.90 percent. This is a 86.76 percent increase over sales of $2.832 million the same period last year.